Cargando…

Prevention of COVID-19 in patients with IBD – Authors' reply

Detalles Bibliográficos
Autores principales:	Ding, Nik Sheng, An, Ping, Dong, Weiguo, Ding, Yijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295529/ https://www.ncbi.nlm.nih.gov/pubmed/32553142 http://dx.doi.org/10.1016/S2468-1253(20)30156-4

Ejemplares similares

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic. Authors' reply
por: King, Dominic Stephen, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with IBD
por: Segal, Jonathan P, et al.
Publicado: (2020)

Emotional state should not be used to differentiate IBD from IBS – Authors' reply
por: Iacucci, Marietta, et al.
Publicado: (2020)

The authors reply
por: Su, Hua, et al.
Publicado: (2020)

Workup of cerebral involvement in patients with COVID-19 – authors’ reply
por: Chen, Chi-Sheng, et al.
Publicado: (2023)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Probiotics and COVID-19 – Authors' reply
por: Mak, Joyce W Y, et al.
Publicado: (2020)

Author’s Reply—Is it really COVID-19?
por: Chang, David, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis
por: Burgueño, Juan F, et al.
Publicado: (2020)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

COVID-19 in pregnant women – Authors' reply
por: Baud, David, et al.
Publicado: (2020)

Feasibility of controlling COVID-19 – Authors' reply
por: Eggo, Rosalind M, et al.
Publicado: (2020)

Nicaragua's response to COVID-19 – Authors' reply
por: Jarquín, Mateo C, et al.
Publicado: (2020)

Author's Reply
por: Park, Dong Il
Publicado: (2014)

Circumcision for HIV Prevention: Authors' Reply
por: Kahn, James G, et al.
Publicado: (2007)

Author Correction: Management of IBD during the COVID-19 outbreak: resetting clinical priorities
por: Danese, Silvio, et al.
Publicado: (2020)

Risk factors for in-hospital mortality in patients with cancer and COVID-19 – Authors' reply
por: Yang, Kunyu, et al.
Publicado: (2020)

Author's reply
por: Park, Chul Hyun, et al.
Publicado: (2018)

Author's Reply
por: So, Hoonsub, et al.
Publicado: (2015)

Gastrointestinal and liver involvement in patients with COVID-19 – Authors' reply
por: Qiu, Yun, et al.
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Authors’ Reply: Vaccination, payment, and COVID-19
por: Dotlic, Jelena, et al.
Publicado: (2021)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre
por: Zingone, Fabiana, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

IBD in the Time of COVID19
por: Moss, Alan, et al.
Publicado: (2020)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f1jcmt1ed487ii11ecvrrnsit3